16 Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis

17 HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.

18 TDAH: remissão na adolescência e preditores de persistência em adultos ADHD: Remission in adolescence and predictors of persistence into adulthood

19 ADHD remission, inclusive special education, and socioeconomic disparities

20 Unilateral remote temperature monitoring to predict future ulceration for the diabetic foot in remission

21 Behaviour change, weight loss and remission of Type 2 diabetes: a community-based prospective cohort study.

22 Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis

23 Identification of targetable BRAF ΔN486_P490 variant by whole genome sequencing leading to dabrafenib-induced remission of a BRAF-mutant pancreatic adenocarcinoma.

24 Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.

25 Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly.

26 Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial.

27 Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss.

28 Type 2 Diabetes Mellitus (T2DM) “Remission” in Non-bariatric Patients 65 Years and Older

29 Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.

30 Association of CD204 macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT.

31 New Metrics to Assess Type 2 Diabetes After Bariatric Surgery: The "Time-Within-Remission Range".

32 Parallel but connected: Nuances of conducting behavioral and social science research alongside ethically challenging HIV remission trials

33 Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

34 Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1

35 Certolizumab pegol for induction of remission in Crohn's disease

36 Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

37 Calorie restriction for long-term remission of type 2 diabetes

38 Remission and withdrawal of therapy in lupus nephritis

39 Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis

40 Enteral nutritional therapy for induction of remission in Crohn's disease

41 Vedolizumab for induction and maintenance of remission in ulcerative colitis

42 Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis

43 Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

44 Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

45 Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

46 [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]

47 Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991

48 Report by the ACNP Task Force on response and remission in major depressive disorder

49 Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial

50 Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

51 Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial

52 Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

53 correlation of endoscopic findings of gastric mucosa-associated lymphoid tissue lymphoma with recurrence after complete remission

54 response to: remission of hidradenitis suppurativa after bariatric surgery

55 hypopigmented mycosis fungoides: clinical, histological, and immunohistochemical remission induced by narrow-band ultraviolet b

56 prolonged remission of pemphigus induced by dexamethasone-cyclophosphamide pulse therapy

57 complete remission of nephrotic syndrome and acute kidney injury in crescentic iga nephropathy: role of mycophenolate sodium

58 comparison of direct immunofluorescence of plucked hair and skin for evaluation of immunological remission in pemphigus

59 primary cutaneous anaplastic large-cell lymphoma: complete remission for 13 years after denileukin diftitox

60 sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

61 fibromyalgia syndrome: a case report on controlled remission of symptoms by a dietary strategy

62 roux-en y gastric bypass results in long-term remission of hepatocyte apoptosis and hepatic histological features of non-alcoholic steatohepatitis

63 unanticipated rapid remission of refractory bulimia nervosa, during high-dose repetitive transcranial magnetic stimulation of the dorsomedial prefrontal cortex: a case report

64 long-term remission of primary bone marrow diffuse large b-cell lymphoma treated with high-dose chemotherapy rescued by in vivo rituximab-purged autologous stem cells

65 tumour lysis syndrome and partial remission occurring after administration of a test dose of obinutuzumab

66 sustained remission in a case of lupus nephritis with cyclosporin therapy

67 complete psa remission without adjuvant therapy after secondary lymph node surgery in selected patients with biochemical relapse after radical prostatectomy and pelvic lymph node dissection

68 maintaining remission in distal ulcerative colitis and ulcerative proctitis

69 complete remission of nephrotic syndrome of hepatitis b virus-associated membranous glomerulopathy after lamivudine monotherapy

70 impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma

71 The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing's disease.

72 Deep remission in inflammatory bowel disease: looking beyond symptoms

73 Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab

74 Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease

75 Adalimumab induces deep remission in patients with Crohn's disease

76 Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease

77 Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis

78 Unconventional success: Achieving long-term remission with pembrolizumab in recurrent high-grade endometrial carcinosarcoma.

Keyword Connections

Journals

Research Groups

Bibliographies